OR4A21P

Across TCGA pan-cancer cohorts, OR4A21P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated OR4A21P data layer compared with 1 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher OR4A21P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4A21P expression acts as an unfavorable survival marker.

KIRC, UCEC, and KIRP are the cancer types where OR4A21P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.214	0.623	.025	48	view →
UCEC	DFS	Tertile	All	0.111	0.652	<.001	36	view →
KIRP	OS	Tertile	III,IV	0.268	0.808	.012	21	view →
SKCM	OS	Tertile	III,IV	0.216	0.721	.001	18	view →
SARC	DFS	Tertile	All	0.217	0.596	.041	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

OR4A21P–KIRC (DFS)

Open the KIRC breakdown →